NUTRA PHARMA CORP. Deferred Compensation Equity
NUTRA PHARMA CORP. (NPHC) had Deferred Compensation Equity of $10.25 thousand as of 2022-03-31, per its 10-Q filed 2022-05-20.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2025-09-03
- 2022-03-31: Deferred Compensation Equity $10.25K.
- 2021-12-31: Deferred Compensation Equity $20.50K.
- 2021-09-30: Deferred Compensation Equity $83.81K.
- 2021-06-30: Deferred Compensation Equity $31.55K.
| Period end | Deferred Compensation Equity |
|---|---|
| 2022-03-31 | $10.25K 10-Q · filed 2022-05-20 |
| 2021-12-31 | $20.50K 10-K · filed 2025-09-03 |
| 2021-09-30 | $83.81K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $31.55K 10-Q · filed 2021-09-24 |
| 2011-12-31 | $0.00 10-K/A · filed 2012-11-15 |
| 2011-09-30 | $272.00K 10-Q · filed 2011-11-15 |
| 2011-06-30 | $408.00K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $212.50K 10-K/A · filed 2012-11-15 |